Conagra Brands, Inc.

New York Stock Exchange
Somewhat Bearish -25

Conagra Brands stock heads into the open after a 0.5 percent dip

πŸ“‰ Conagra Brands stock closed at USD 15.10 on September 18, 2026, down 0.55 percent and roughly 12.8 percent below its year-opening level.

🎯 The consensus price target stands at USD 14.10 per share, implying about 6.6 percent downside from the recent closing level.

πŸ“Š Analyst ratings are predominantly in the hold range, with more hold and sell recommendations than buy ratings according to MarketBeat.

πŸ’Š GLP-1 weight loss medications impacting appetite and food consumption patterns have become a recurring theme in analyst discussions regarding Conagra's positioning.

πŸ– Record demand for the Slim Jim brand is being closely monitored as a key indicator of performance amidst changing consumer health preferences.

πŸ“ˆ Investors are watching for updates on packaged food demand or input cost trends that could influence expectations for the next quarterly results.

Bullish Signals
  • Conagra Brands is experiencing record demand for its Slim Jim brand, which serves as a key indicator of performance amidst changing consumer health preferences.
  • The current market price of USD 15.10 stands modestly above the consensus price target of USD 14.10, indicating that the stock trades at a premium to analyst fair value estimates.
Risk Factors
  • Conagra Brands shares are down approximately 12.8 percent year-to-date as of September 18, 2026, underscoring weaker performance compared to broader consumer staples names.
  • Analyst consensus ratings are predominantly in the hold range with more sell recommendations than buy ratings, suggesting cautious sentiment from market professionals.
Full Analysis
Conagra Brands stock opened on September 21, 2026, following a session on September 18 where shares closed at USD 15.10 on the New York Stock Exchange. The stock finished down 0.55 percent for the day, trading between USD 15.01 and USD 15.18 as the broader S&P 500 index slipped modestly. This performance kept Conagra roughly in line with the wider market but highlighted its weaker trajectory compared to other consumer staples names. As of September 18, 2026, the shares were approximately 12.8 percent below their level at the start of the year, reflecting a challenging year-to-date performance. Analyst consensus price targets stand at USD 14.10 per share, implying about 6.6 percent downside from the recent closing price. The stock currently carries an average rating score around the hold range, with more hold and sell recommendations than buy ratings according to MarketBeat data. Market attention is focused on broader consumer and inflation data, sector sentiment, and potential updates regarding packaged food demand or input cost trends that could influence expectations for the next quarterly results. Analyst discussions are heavily influenced by Conagra's strategy around branded snacks and its positioning relative to changing consumer health preferences. Specifically, the impact of GLP-1 weight loss medications on appetite and food consumption patterns has become a recurring theme in market analysis. Recent coverage emphasizes that record demand for the Slim Jim brand and management's ongoing commentary on GLP-1 related consumption changes have featured prominently in recent market analysis. Any fresh remarks from the company or covering analysts on these topics today could shape sentiment ahead of the next earnings release, making these specific product dynamics critical to the stock's near-term outlook.